An experiment launched to the International Space Station on a Dragon capsule in August 2017 for the Michael J. Fox Foundation is discussed. Researchers are searching for a drug that can bind to the faulty proteins, disabling them and potentially stop Parkinson's progression in those patients. Among them includes the Parkinson's protein of interest--dubbed LRRK2 ("LURK- two") --was shipped in a frozen state to the Kennedy Space Center in Florida, where bits of hardware about the size of Band-Aids, called Microlytic Crystal Former Optimization Chips, held fluidic samples of the protein in 16 tube-like channels; once thawed on orbit, the protein mixed with other chemicals that promote crystallization.


    Access

    Access via TIB

    Check availability in my library

    Order at Subito €


    Export, share and cite



    Title :

    Space station experiment targets Parkinson's


    Contributors:

    Published in:

    Publication date :

    2017



    Type of media :

    Article (Journal)


    Type of material :

    Print


    Language :

    English



    Classification :

    BKL:    55.88 Luftverkehr, Raumfahrt / 55.88
    Local classification TIB:    770/7040



    Space station experiment cabin structure

    LUO BIN / LI LICHUN / BAI HEMIN et al. | European Patent Office | 2025

    Free access


    The Space Station structural characterization experiment

    Johnson, James W. / Cooper, Paul A. | NTRS | 1988


    Space station expansion exposure experiment platform

    LI ZHE / LUO WENCHENG / PAN PING et al. | European Patent Office | 2024

    Free access

    Space Station Based Microacceleration Experiment Platform

    Barber, Katy / Economopoulos, Tony / Evenson, Erik et al. | NTRS | 1990